From: Spectrum of malignant and premalignant skin lesions in 505 adult subjects at risk of skin cancers
Univariate OR | P-value | 95% CI | Multivariate OR | P-value | 95% CI | |
---|---|---|---|---|---|---|
Age years | 1.042 | 0.026 | 1.005–1.081 | 1.099 | 0.001 | 1.040–1.160 |
Sex | ||||||
Male | 1 (ref) | 1 (ref) | ||||
Female | 0.843 | 0.513 | 0.504–1.408 | 0.560 | 0.110 | 0.275–1.140 |
Immunosuppression | ||||||
No | 1 (ref) | 1 (ref) | ||||
Yes | 1.000 | 1.000 | 0.507–1.973 | 1.118 | 0.807 | 0.456–2.738 |
Past or present extracutaneous malignancy | 0.028 | 1.117–7.219 | ||||
No | 1 (ref) | 1 (ref) | ||||
Yes | 2.745 | 0.009 | 1.287–5.855 | 2.839 | 0.028 | 1.117–7.219 |
Occupation type | ||||||
mainly indoor | 1 (ref) | 1 (ref) | ||||
mainly outdoor/mix | 0.695 | 0.175 | 0.411–1.175 | 0.507 | 0.049 | 0.258–0.998 |
Lifetime sunburns | ||||||
rarely | 1 (ref) | 1 (ref) | ||||
occasionally | 0.834 | 0.542 | 0.465-1.495 | 0.921 | 0.817 | 0.457–1.856 |
often | 1.375 | 0.372 | 0.684–2.765 | 2.045 | 0.092 | 0.889–4.700 |
Number of moles | ||||||
0–20 | 1 (ref) | 1 (ref) | ||||
21–50 | 1.9531 | 0.042 | 1.026–3.719 | 2.557 | 0.018 | 1.175–5.565 |
51–100 | 1.492 | 0.403 | 0.584–3.809 | 1.132 | 0.821 | 0.388–3.307 |
over 100 moles | 1.046 | 0.938 | 0.336–3.260 | 1.624 | 0.505 | 0.390–6.775 |
Alcohol consumption | ||||||
never | 1 (ref) | 1 (ref) | ||||
≤ 1x /month | 1.497 | 0.317 | 0.679–3.303 | 2.375 | 0.076 | 0.914–6.174 |
3-4x /month | 0.948 | 0.897 | 0.421–2.132 | 1.125 | 0.822 | 0.404–3.131 |
1-2x/week or more | 1.176 | 0.706 | 0.506–2.738 | 1.019 | 0.974 | 0.343–3.023 |
Platelet-to-lymphocyte-ratio | 1.000 | 0.880 | 0.995–1.004 | 0.999 | 0.853 | 0.994–1.005 |
Number of AKs diagnosed at the visit | ||||||
0 | 1 (ref) | 1 (ref) | ||||
1–3 | 0.636 | 0.201 | 0.318–1.272 | 0.524 | 0.138 | 0.223–1.231 |
4–10 | 0.618 | 0.226 | 0.284–1.346 | 0.246 | 0.008 | 0.088–0.691 |
over 10 | 0.651 | 0.336 | 0.272–1.561 | 0.252 | 0.020 | 0.079–0.807 |
PAASI score | 1.005 | 0.152 | 0.998–1.011 | 1.003 | 0.399 | 0.996–1.011 |